Market
Noni extract (from Morinda citrifolia) in the United States is primarily positioned as a botanical dietary ingredient used by downstream dietary supplement and functional-product manufacturers rather than as a nationally tracked primary crop commodity. U.S. market access is compliance-driven: imports offered for U.S. commerce are subject to FDA import requirements such as Prior Notice and (where applicable) food facility registration verification, alongside U.S. customs entry processes. For dietary supplement applications, U.S. manufacturing/holding operations are governed by dietary supplement CGMP requirements in 21 CFR Part 111. Morinda citrifolia is documented in Hawai'i, but public, product-specific statistics for U.S. noni-extract production and trade are limited in commonly cited government datasets.
Market RoleImport-dependent consumer and formulating market (dietary supplements and functional products)
Domestic RoleDownstream formulation/manufacturing market for botanical extracts used as dietary ingredients
Risks
Regulatory Compliance HighShipments of noni extract offered for import into the United States can be delayed, detained, or refused if FDA import requirements are not met (e.g., missing/incorrect Prior Notice and/or mismatches in information used for FDA verification of food facility registration as applicable), alongside U.S. customs entry processing requirements.Use a pre-shipment compliance checklist covering FDA Prior Notice submission/confirmation, accurate facility identifiers where required, and coordinated broker/importer entry data to support FDA admissibility screening and CBP entry processing.
Labeling And Claims HighFor U.S. dietary supplement products containing noni extract, disease-treatment claims are not permitted for supplements; noncompliant claims can trigger FDA enforcement actions and disrupt market access.Constrain claims to compliant categories (e.g., structure/function where applicable), maintain substantiation, include required disclaimers, and submit required FDA claim notifications within required timelines.
Food Safety MediumBotanical dietary ingredients and finished supplements face ongoing U.S. market scrutiny for undeclared contaminants/adulterants and label accuracy; third-party standards/certification are often used to reduce buyer and retailer risk.Implement supplier qualification and lot-based testing (identity and contaminants) and consider certification programs aligned with NSF/ANSI 173 where commercially required.
Supplier Verification MediumIf FSVP applies, inadequate hazard analysis, supplier approval, verification activities, or recordkeeping by the U.S. importer can create compliance exposure and disrupt imports.Maintain an FSVP program aligned to 21 CFR Part 1 Subpart L, including documented hazard evaluation, supplier verification activities, and retrievable records.
Standards- NSF/ANSI 173 certification (dietary supplements and dietary ingredients)
FAQ
What are the most common U.S. import compliance steps for noni extract shipments?For shipments offered for import as food/dietary ingredients, FDA generally requires Prior Notice in advance of arrival and may verify food facility registration as applicable; imports also follow U.S. Customs entry processing, including cargo release filing and entry summary procedures.
Which U.S. GMP rule is most relevant when noni extract is used in dietary supplements?Dietary supplement manufacturing, packaging, labeling, and holding operations are subject to the dietary supplement CGMP regulation in 21 CFR Part 111.
Can U.S. dietary supplements containing noni extract make disease-treatment claims?No. FDA distinguishes permissible structure/function claims from disease claims for dietary supplements; disease-treatment claims are reserved for drugs, and structure/function claims have specific substantiation, disclaimer, and notification requirements.
When might a New Dietary Ingredient (NDI) notification be relevant in the U.S.?If the ingredient used in a dietary supplement meets the definition of a “new dietary ingredient,” FDA describes an NDI notification process that manufacturers or distributors may need to follow before marketing the supplement under the labeled conditions of use.